Leukaemia (chronic lymphocytic, first line) - rituximab: Appendix B proposal paper presented to the Institute's Guidance Executive

Leukaemia (chronic lymphocytic, first line) - rituximab: Appendix B proposal paper presented to the Institute's Guidance Executive

Leukaemia (chronic lymphocytic, first line) - rituximab: Appendix B proposal paper presented to the Institute's Guidance Executive
20 January 2014
(446.11 Kb 9 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 14 January 2014